New acetamide derivatives of quinazoline-2,4(1H,3H)-dione: neural network prediction, synthesis, and psychotropic activity

被引:0
作者
M. A. Perfilev
P. M. Vassiliev
A. A. Ozerov
D. V. Maltsev
A. R. Pluzhnikova
D. V. Merezhkina
机构
[1] Volgograd State Medical University of the Ministry of Healthcare of the Russian Federation,
[2] Volgograd Medical Research Center,undefined
来源
Russian Chemical Bulletin | 2023年 / 72卷
关键词
multiple docking; artificial neural networks; structure—activity relationship; GABA; -agonistic activity; quinazolines; psychotropic activity;
D O I
暂无
中图分类号
学科分类号
摘要
Multiple docking of five new acetamide derivatives of 1-methylquinazoline-2,4(1H,3H)-dione was carried out over the entire GABAA receptor (gamma-butyric acid type A receptor) and the energy spectra of multiple docking were calculated. Using a model based on multiple docking and artificial neural networks technology, the level of GABAA agonistic activity of these compounds was predicted. One promising compound with possible high GABAA agonistic activity was identified. Synthesis of five new acetamide derivatives of 1-methylquinazorine-2,4(1H,3H)-dione was accomplished. The psychotropic activity of the synthesized compounds was studied in the open field behavioral test. One compound was found to have a pronounced priming effect, comparable to that of the reference drug diazepam. This active compound was recommended for further in-depth study of its anxiolytic and antidepressant properties. The predictive accuracy of the technology developed in silico was 100%, which allowed us to recommend it for a directed search for innovative drugs with various types of pharmacological action.
引用
收藏
页码:1075 / 1082
页数:7
相关论文
共 64 条
[1]  
Calcaterra N E(2014)undefined ACS Chem. Neuroscience 5 4-undefined
[2]  
Barrow J C(2017)undefined Russ. Chem. Bull. 66 2-undefined
[3]  
Kelbysheva E S(2020)undefined Russ. Chem. Bull. 69 11-undefined
[4]  
Telegina L N(2015)undefined Mol. Pharmacol. 88 2-undefined
[5]  
Ershova E A(2017)undefined Bioorg. Med. Chem. 25 3-undefined
[6]  
Strelkova T V(2019)undefined Fundam. Clin. Pharmacol. 33 1-undefined
[7]  
Ezernitskaya M G(2019)undefined Int. J. Mol. Sci. 20 4331-undefined
[8]  
Nosova E V(2019)undefined Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 13 3-undefined
[9]  
Smol’yakov A F(2018)undefined Nature 559 7712-undefined
[10]  
Dolgushin F M(2010)undefined J. Comp. Chem. 31 2-undefined